» Articles » PMID: 33301493

Analyzing Changes in Respiratory Rate to Predict the Risk of COVID-19 Infection

Overview
Journal PLoS One
Date 2020 Dec 10
PMID 33301493
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

COVID-19, the disease caused by the SARS-CoV-2 virus, can cause shortness of breath, lung damage, and impaired respiratory function. Containing the virus has proven difficult, in large part due to its high transmissibility during the pre-symptomatic incubation. The study's aim was to determine if changes in respiratory rate could serve as a leading indicator of SARS-CoV-2 infections. A total of 271 individuals (age = 37.3 ± 9.5, 190 male, 81 female) who experienced symptoms consistent with COVID-19 were included- 81 tested positive for SARS-CoV-2 and 190 tested negative; these 271 individuals collectively contributed 2672 samples (days) of data (1856 healthy days, 231 while infected with COVID-19 and 585 while negative for COVID-19 but experiencing symptoms). To train a novel algorithm, individuals were segmented as follows; (1) a training dataset of individuals who tested positive for COVID-19 (n = 57 people, 537 samples); (2) a validation dataset of individuals who tested positive for COVID-19 (n = 24 people, 320 samples); (3) a validation dataset of individuals who tested negative for COVID-19 (n = 190 people, 1815 samples). All data was extracted from the WHOOP system, which uses data from a wrist-worn strap to produce validated estimates of respiratory rate and other physiological measures. Using the training dataset, a model was developed to estimate the probability of SARS-CoV-2 infection based on changes in respiratory rate during night-time sleep. The model's ability to identify COVID-positive individuals not used in training and robustness against COVID-negative individuals with similar symptoms were examined for a critical six-day period spanning the onset of symptoms. The model identified 20% of COVID-19 positive individuals in the validation dataset in the two days prior to symptom onset, and 80% of COVID-19 positive cases by the third day of symptoms.

Citing Articles

Noninvasive Early Detection of Systemic Inflammatory Response Syndrome of COVID-19 Inpatients Using a Piezoelectric Respiratory Rates Sensor.

Kobayashi T, Matsui T, Sugita I, Tateda N, Sato S, Hashimoto K Sensors (Basel). 2024; 24(22).

PMID: 39598879 PMC: 11598245. DOI: 10.3390/s24227100.


Feasibility of snapshot testing using wearable sensors to detect cardiorespiratory illness (COVID infection in India).

Botonis O, Mendley J, Aalla S, Veit N, Fanton M, Lee J NPJ Digit Med. 2024; 7(1):289.

PMID: 39427067 PMC: 11490565. DOI: 10.1038/s41746-024-01287-2.


A Novel Sensible Smart Mask Using Micro Thermal-Electric Energy Conversion Elements.

Zhang Y, Xiao Z, Liu B, Ren X, Liu C Micromachines (Basel). 2024; 15(8).

PMID: 39203642 PMC: 11356143. DOI: 10.3390/mi15080991.


Study of Postacute Sequelae of COVID-19 Using Digital Wearables: Protocol for a Prospective Longitudinal Observational Study.

El-Toukhy S, Hegeman P, Zuckerman G, Das A, Moses N, Troendle J JMIR Res Protoc. 2024; 13:e57382.

PMID: 39150750 PMC: 11364950. DOI: 10.2196/57382.


Development and validation of a predictive model for pulmonary infection risk in patients with traumatic brain injury in the ICU: a retrospective cohort study based on MIMIC-IV.

Shi Y, Hu Y, Xu G, Ke Y BMJ Open Respir Res. 2024; 11(1).

PMID: 39089740 PMC: 11867668. DOI: 10.1136/bmjresp-2023-002263.


References
1.
Lai C, Shih T, Ko W, Tang H, Hsueh P . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924. PMC: 7127800. DOI: 10.1016/j.ijantimicag.2020.105924. View

2.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

3.
He X, Lau E, Wu P, Deng X, Wang J, Hao X . Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020; 26(5):672-675. DOI: 10.1038/s41591-020-0869-5. View

4.
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C . Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020; 382(10):970-971. PMC: 7120970. DOI: 10.1056/NEJMc2001468. View

5.
Lauer S, Grantz K, Bi Q, Jones F, Zheng Q, Meredith H . The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020; 172(9):577-582. PMC: 7081172. DOI: 10.7326/M20-0504. View